국가: 미국
언어: 영어
출처: NLM (National Library of Medicine)
ADAPALENE (UNII: 1L4806J2QF) (ADAPALENE - UNII:1L4806J2QF)
Allegis Pharmaceuticals, LLC
TOPICAL
PRESCRIPTION DRUG
Adapalene Topical Solution 0.1% is indicated for the topical treatment of acne vulgaris. Adapalene Topical Solution 0.1% should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle solution.
Adapalene Topical Solution 0.1% is supplied in the following size: 60mL glass bottle - NDC 28595-530-60 Store at 20' to 25'C (68' to 77'F). [See USP controlled room temperature] CAUTION: Federal law prohibits dispensing without prescription.
Abbreviated New Drug Application
ADAPALENE- ADAPALENE SOLUTION ALLEGIS PHARMACEUTICALS, LLC ---------- ADAPALENE TOPICAL SOLUTION 0.1% RX ONLY DESCRIPTION Adapalene Topical Solution 0.1%, containing adapalene is used for the topical treatment of acne vulgaris. Each ml of Adapalene Topical Solution, 0.1%, contains adapalene 0.1% (1mg) in a vehicle consisting of polyethylene glycol 400 and alcohol, denatured, 30% (w/v). The chemical name of adapalene is 6-[3-(l-adamantyl)-4-methoxyphenyl]-2-naphthoic acid. Adapalene is a white to off-white powder which is soluble in tetrahydrofuran, sparingly soluble in ethanol, and practically insoluble in water. The molecular formula is C, H, O, and molecular weight is 412.52. Adapalene is represented by the following structural formula: CLINICAL PHARMACOLOGY Adapalene is a chemically stable, retinoid-like compound. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization, and inflammatory processes all of which represent important features in the pathology of acne vulgaris. Mechanistically, adapalene binds to specific retinoic acid nuclear receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action is unknown, IT is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation. PHARMACOKINELICS Absorption of adapalene through human skin is low. Only trace amounts (< 0.25 ng/ml) of parent substance have been found in the plasma of acne patients following chronic topical application of adapalene in controlled clinical trials. Excretion appears to be primarily by the biliary route. INDICATIONS AND USAGE Adapalene Topical Solution 0.1% is indicated for the topical treatment of acne vulgaris. CONTRAINDICATIONS Adapalene Topical Solution 0.1% should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle solution. WARNINGS Use of Adapalene Topical Solution 0.1% sh 전체 문서 읽기